CHU Estaing

The trials here

What the 24 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia6 trials
• Childhood cancers5 trials
• Liver and biliary tract cancer4 trials
• Myelodysplastic syndromes3 trials
• Mantle cell lymphoma2 trials
• Pancreatic cancer2 trials
• Atopic dermatitis (eczema)1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Colorectal cancer1 trial
• Endometriosis1 trial
• Haemophilia1 trial

Phase

• Phase 35 trials
• Phase 23 trials
• Phase 2/33 trials
• Phase 1/21 trial

Status

• Active, not recruiting7 trials
• Recruiting7 trials
• Completed6 trials
• Not yet recruiting3 trials
• Terminated1 trial

Lead sponsor

• Assistance Publique - Hôpitaux de Paris3 trials
• French Innovative Leukemia Organisation3 trials
• Groupe Francophone des Myelodysplasies3 trials
• Federation Francophone de Cancerologie Digestive2 trials
• The Lymphoma Academic Research Organisation2 trials
• and 11 more

Running trials

• Not yet recruiting

  Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

  NCT07437287· Phase 2/3· UNICANCER· Source

  Contact: Nicolas DE SOUSA CARVALHO

• Not yet recruiting

  Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

  NCT06999512· Phase 2/3· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Joan GAGNIERE (principal investigator)

• Recruiting

  OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

  NCT06377579· French Innovative Leukemia Organisation· Source

  Contact: Gaspar Aspas Requena, MD

• Recruiting

  Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA

  NCT06207981· Phase 3· Federation Francophone de Cancerologie Digestive· Source

  Contact: Marine JARY

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Institut Claudius Regaud· Source

  Contact: Justyna KANOLD

• Recruiting

  Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies

  NCT05772559· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Justyna Kanold, MD

• Recruiting

  A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

  NCT05689151· Pfizer· Source

• Recruiting

  Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

  NCT05521776· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Denis GALOT, Dr

• Active, not recruiting

  Evaluation of the Efficacy of HIFU Treatment on Rectal Endometriosis Symptoms.

  NCT05755958· EDAP TMS S.A.· Source

• Recruiting

  MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

  NCT05691608· Gustave Roussy, Cancer Campus, Grand Paris· Source

  Contact: Justyna KANOLD, Dr

• Active, not recruiting

  Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

  NCT04802590· Phase 2· The Lymphoma Academic Research Organisation· Source

• Active, not recruiting

  Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

  NCT03766763· Phase 2· French Innovative Leukemia Organisation· Source

• Active, not recruiting

  A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

  NCT03383458· Phase 3· Bristol-Myers Squibb· Source

• Active, not recruiting

  A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

  NCT03223961· Phase 3· Groupe Francophone des Myelodysplasies· Source

• Active, not recruiting

  Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)

  NCT02767063· Phase 1/2· Versailles Hospital· Source

• Recruiting

  Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

  NCT06891144· French Innovative Leukemia Organisation· Source

  Contact: romain Guièze, Prof

• Active, not recruiting

  Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

  NCT02870907· Phase 2· Institut Curie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia4 recruiting
• Childhood cancers3 recruiting
• Liver and biliary tract cancer2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Colorectal cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

  NCT05437211· Takeda· Source

• Completed

  Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

  NCT05665348· Phase 2/3· Federation Francophone de Cancerologie Digestive· Source

• Completed

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· Phase 3· Kyntra Bio· Source

• Terminated

  Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

  NCT03439371· Centre Hospitalier Universitaire de Saint Etienne· Source

• Completed

  Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

  NCT02757989· Groupe Francophone des Myelodysplasies· Source

• Completed

  French Registry of First-line Treatment of Acute Promyelocytic Leukemia

  NCT02938858· Groupe Francophone des Myelodysplasies· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· The Lymphoma Academic Research Organisation· Source